Boston An independent LDT provider

Press releases

January 16, 2017 | REGULATORY

University of Michigan Pancreatic Cancer Center new partner in Immunovia’s global PANFAM-1 prospective validation study

Read press release
January 13, 2017

Immunovia bjuder in till telefonkonferens tisdag 17/1 kl 16:00

Read press release
January 12, 2017 | REGULATORY

Immunovia announces first data exceeding 90% accuracy in distinguishing systemic lupus erythematosus (SLE) from other autoimmune diseases in new study

Read press release
December 22, 2016

Immunovia Shareholder Newsletter Q4 2016

Read press release
December 20, 2016 | REGULATORY

Immunovia announces the start of PANFAM-1, the largest ever prospective multi-center clinical study for early detection of pancreatic cancer

Read press release
December 9, 2016 | REGULATORY

Summary from the extraordinary general meeting of Immunovia

Read press release
December 9, 2016 | REGULATORY

Immunovia announces collaboration with NCI, regarding early detection of pancreatic cancer in the new onset diabetes risk group

Read press release
December 9, 2016 | REGULATORY

Immunovia announces collaboration with the renowned Ramon y Cajal Institute for Health Research (IRYCIS) in Madrid

Read press release
November 18, 2016 | REGULATORY

Immunovia awarded 2016 Stars of Innovation Prize

Read press release
November 16, 2016 | REGULATORY

KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB (publ)

Read press release
November 15, 2016

WORLD PANCREATIC CANCER DAY, LUND SWEDEN, November 17, 2016 – It’s About Time

Read press release
October 19, 2016 | REGULATORY

Immunovia announces completion of preferential rights issue of SEK 28.7 million, adding to previously SEK 189.9 million directed issue

Read press release
1 17 18 19 20 21 22